HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.

Abstract
Acanthoic acid, a pimaradiene diterpene isolated from Acanthopanax koreanum, has been reported to have anti-inflammatory activities. However, the effects of acanthoic acid on LPS-induced acute lung injury have not been reported. The purpose of this study was to investigate the protective effect of acanthoic acid on LPS-induced ALI and to clarify the possible anti-inflammatory mechanisms. In vivo, an LPS-induced ALI model in mice was used to assess the protective effects of acanthoic acid on ALI. Meanwhile, mouse alveolar macrophages MH-S were stimulated with LPS in the presence or absence of acanthoic acid. The expressions of TNF-α, IL-6 and IL-1β were measured by ELISA. LXRα and NF-κB expression were detected by Western blot analysis. The results showed that acanthoic acid downregulated LPS-induced TNF-α, IL-6 and IL-1β production in BALF. MPO activity and lung wet-to-dry ratio were also inhibited by acanthoic acid. In addition, acanthoic acid attenuated lung histopathologic changes. In vitro, acanthoic acid inhibited inflammatory cytokines TNF-α, IL-6 and IL-1β production and NF-κB activation in LPS-stimulated alveolar macrophages. Acanthoic acid was found to up-regulated the expression of LXRα. The inhibition of acanthoic acid on LPS-induced cytokines and NF-κB activation can be abolished by LXRα siRNA. In conclusion, our results suggested that the protective effect of acanthoic acid on LPS-induced ALI was due to its ability to activate LXRα, thereby inhibiting LPS-induced inflammatory response.
AuthorsWang Qiushi, Li Guanghua, Xu Guangquan
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 750 Pg. 32-8 (Mar 05 2015) ISSN: 1879-0712 [Electronic] Netherlands
PMID25620130 (Publication Type: Journal Article)
CopyrightCopyright © 2015 Elsevier B.V. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents
  • Diterpenes
  • Interleukin-1beta
  • Interleukin-6
  • Lipopolysaccharides
  • Liver X Receptors
  • NF-kappa B
  • Nr1h3 protein, mouse
  • Orphan Nuclear Receptors
  • Tumor Necrosis Factor-alpha
  • acanthoic acid
  • Peroxidase
Topics
  • Acute Lung Injury (complications, drug therapy, metabolism, pathology)
  • Animals
  • Anti-Inflammatory Agents (pharmacology, therapeutic use)
  • Bronchoalveolar Lavage Fluid
  • Diterpenes (pharmacology, therapeutic use)
  • Edema (complications)
  • Interleukin-1beta (biosynthesis)
  • Interleukin-6 (biosynthesis)
  • Lipopolysaccharides (adverse effects)
  • Liver X Receptors
  • Lung (drug effects, metabolism, pathology)
  • Macrophages, Alveolar (drug effects, metabolism)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • NF-kappa B (metabolism)
  • Orphan Nuclear Receptors (metabolism)
  • Peroxidase (metabolism)
  • Tumor Necrosis Factor-alpha (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: